Both in Pharmaceuticals
Kairos Pharma vs Genprex
Over the past year KAPA returned −93.4% and GNPX returned −98.7%; their daily moves had a correlation of -0.01.
KAPA −93.4% GNPX −98.7%Growth of $1, one year, split-adjusted
| Metric | KAPA | GNPX |
|---|---|---|
| Price | $0.5231 | $2.01 |
| Market cap | $1.8M | $1.6M |
| Today | −1.30% | +3.08% |
| 1 month | −68.5% | −29.5% |
| 6 months | −86.5% | −89.5% |
| Year to date | −89.5% | −94.8% |
| 1 year | −93.5% | −99.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $2.6M | $15.2M |
| Dividend yield | — | — |
| Volatility (60d) | 581.5% | 78.6% |
| Short % of float | 0.9% | 15.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).